The Office of the Additional Director, Medical Store Depot (CGHS), is seeking information from manufacturers and authorized importers to assess local manufacturing capacity for specific medicines. The medicines identified for procurement are Ustekinumab and Golimumab. Interested parties are required to submit detailed documentation, including CDSCO approvals, GST registration, and intellectual property details. Submissions must be made in a sealed envelope or via email to the Medical Store Depot within 15 days of the memorandum issuance. This initiative aims to streamline the procurement process for CGHS beneficiaries.

The Office of the Additional Director, Medical Store Depot (CGHS), is seeking information from manufacturers and authorized importers to assess local manufacturing capacity for specific medicines. The medicines identified for procurement are Ustekinumab and Golimumab. Interested parties are required to submit detailed documentation, including CDSCO approvals, GST registration, and intellectual property details. Submissions must be made in a sealed envelope or via email to the Medical Store Depot within 15 days of the memorandum issuance. This initiative aims to streamline the procurement process for CGHS beneficiaries.